Surgical Endoscopy

, Volume 21, Issue 2, pp 309–314 | Cite as

Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication

  • J. Miholic
  • M. Hoffmann
  • J.J. Holst
  • J. Lenglinger
  • M. Mittlböck
  • H. Bergmann
  • G. Stacher
Article

Abstract

Background

This study was designed to assess the relationship between gastric emptying of glucose solution and the ensuing plasma concentrations of glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and glucose-dependent insulinotropic polypeptide (GIP) in patients having undergone fundoplication for gastroesophageal reflux (GERD).

Subjects and methods

In 10 male patients the emptying of 50% glucose solution was determined scintigraphically and its relationship with plasma glucose, GLP-1, PYY, and GIP concentrations was studied before and 3 months after fundoplication.

Results

In the first 30 min after glucose ingestion, emptying was significantly (p = 0.048) faster after fundoplication than before. Emptying and GLP-1 and GIP correlated: the faster the emptying during the first 30 min the greater the concentrations integrated over that period (p = 0.04; p = 0.01; p = 0.02). Emptying and PYY concentrations were unrelated. In the 120–180 min. period, blood glucose concentrations were lower the faster the emptying in the initial 30 min (p = 0.06) and the entire 50-min recording period (p = 0.03) had been. The GLP-1 concentrations integrated over the first 30 min correlated inversely with the integrated plasma glucose during the third hour after ingestion (p = 0.004).

Conclusions

After fundoplication, gastric emptying may, if accelerated in its initial phases, give rise to greater and earlier increases in plasma glucose, GLP-1, and GIP concentrations and thus to reactive hypoglycemia.

Keywords

Gastric emptying Fundoplication GIP GLP-1 PYY 

References

  1. 1.
    Bae J, Park J, Yang H, Kim J (1998) Nutritional status of gastric cancer patients after total gastrectomy. World J Surg 22:254–261CrossRefPubMedGoogle Scholar
  2. 2.
    Bais JE, Samsom M, Boudesteijn EA, van Rijk PP, Akkermans LM, Gooszen HG (1991) Impact of delayed gastric emptying on the outcome of antireflux surgery. Ann Surg 234:139–146CrossRefGoogle Scholar
  3. 3.
    Collins PJ, Horowitz M, Chatterton BE (1988) Proximal, distal and total stomach emptying of a solid digestible meal in normal subjects. Br J Radiol 61:12–18CrossRefPubMedGoogle Scholar
  4. 4.
    Ekman R, Wahlestedt C, Bottcher G, Sundler F, Hakanson R, Panula P (1986) Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 16:157–168CrossRefPubMedGoogle Scholar
  5. 5.
    Elliott RM, Morgan LM, Tredger A, Deacon S, Wright J, Marks V (1993) Glucagon-like peptide-1 (7–37) amide and the glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute postprandial and 24-h secretion patterns. J Endocrinol 138:159–166CrossRefPubMedGoogle Scholar
  6. 6.
    Farrell TM, Richardson WS, Halkar R, Lyon CP, Galloway KD, Waring JP, Smith CD, Hunter JG (2001) Nissen fundoplication improves gastric motility in patients with delayed gastric emptying. Surg Endosc 15:271–274CrossRefPubMedGoogle Scholar
  7. 7.
    Fehmann HC, Göke R, Göke B (1995) Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 16:390–410CrossRefPubMedGoogle Scholar
  8. 8.
    Flint A, Raben A, Astrup A, Holst JJ (1998) Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515–520CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gebhard B, Holst JJ, Biegelmayer C, Miholic J (2001) Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 46:1915–1923CrossRefPubMedGoogle Scholar
  10. 10.
    Holst JJ, Bersani M (1991) Assays for peptide products of somatostatin gene expression. In Methods in Neurosciences, vol. 5: Neuropeptide Technology, edited by PM Conn. San Diego, CA: Academic Press, pp 322Google Scholar
  11. 11.
    Imamura M (2002) Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides 23:403–407CrossRefPubMedGoogle Scholar
  12. 12.
    Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L (1983) Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin dependent) diabetics. J Clin Endocrinol Metab 56:1306–1312CrossRefPubMedGoogle Scholar
  13. 13.
    le Roux CW, Bloom SR Peptide YY (2005) appetite and food intake. Proc Nutr Soc 64:213–216CrossRefPubMedGoogle Scholar
  14. 14.
    Lindeboom MYA, Vu MK, Ringers J, van Rijn PJJ, Neijenhuis P, Masclee AAM (2003) Function of the proximal stomach after partial versus complete laparoscopic fundoplication. Am J Gastroenterol 98:284–290CrossRefPubMedGoogle Scholar
  15. 15.
    Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327–1332PubMedGoogle Scholar
  16. 16.
    Maddern GJ, Jamieson GG (1985) Fundoplication enhances gastric emptying. Ann Surg 210:296–299CrossRefGoogle Scholar
  17. 17.
    Miholic J, Ørskov C, Holst JJ, Kotzerke J, Meyer HJ (1991) Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36:1361–1370CrossRefPubMedGoogle Scholar
  18. 18.
    Miholic J, Reilmann L, Meyer HJ, Körber H, Kotzerke J, Hecker H (1990) Extracellular space, blood volume, and the early dumping syndrome after total gastrectomy. Gastroenterology 99:923–929CrossRefPubMedGoogle Scholar
  19. 19.
    Naito H, Sasaki I, Matsuno S (1998) Surgical aspects of enteroinsular axis after gastrointestinal surgery with reference to incretin secretion. Pancreas 16:370–378CrossRefPubMedGoogle Scholar
  20. 20.
    Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W (1989) Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin 8. J Clin Endocrinol Metab 69:654–662CrossRefPubMedGoogle Scholar
  21. 21.
    Neumayer C, Ciovica R, Gadenstatter M, Erd G, Leidl S, Lehr S, Schwab G (2005) Significant weight loss after laparoscopic Nissen fundoplication. Surg Endosc 19:15–20CrossRefPubMedGoogle Scholar
  22. 22.
    Ørskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide-1 in humans. Diabetes 43:535–539CrossRefPubMedGoogle Scholar
  23. 23.
    Patriti A, Facchiano E, Sanna A, Gulla N, Donini A (2004) The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 14:840–848CrossRefPubMedGoogle Scholar
  24. 24.
    Stacher G, Lenglinger J, Bergmann H, Schneider C, Hoffmann M, Wölfl G, Stacher-Janotta G (2000) Gastric emptying—a contributory factor in gastro-oesophageal reflux activity? Gut 47:661–666CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Toft-Nielsen M, Madsbad S, Holst JJ (1998) Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 41:1180–1186CrossRefPubMedGoogle Scholar
  26. 26.
    Vecht J, Masclee AA, Lamers CB (1997) The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment. Scand J Gastroenterol 223(Suppl):21–27Google Scholar
  27. 27.
    Viljakka M, Saali K, Koskinen M, Karhumäki L, Kössi J, Luostarinen M, Teerenhovi O, Isolauri J (1999) Antireflux surgery enhances gastric emptying. Arch Surg 134:18–21CrossRefPubMedGoogle Scholar
  28. 28.
    Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ (1994) Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 29:501–505CrossRefPubMedGoogle Scholar
  29. 29.
    Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ (1993) Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665–673CrossRefPubMedGoogle Scholar
  30. 30.
    Yamashita Y, Toge T, Adrian TE (1997) Gastrointestinal hormone in dumping syndrome and reflux esophagitis after gastric surgery. J Smooth Muscle Res 33:37–48CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • J. Miholic
    • 1
  • M. Hoffmann
    • 2
  • J.J. Holst
    • 3
  • J. Lenglinger
    • 4
  • M. Mittlböck
    • 1
  • H. Bergmann
    • 5
  • G. Stacher
    • 1
  1. 1.Division of General SurgeryMedical University of ViennaViennaAustria
  2. 2.Department of Nuclear MedicineMedical University of ViennaViennaAustria
  3. 3.Department of Medical PhysiologyPanum Institute, University of CopenhagenCopenhagenDenmark
  4. 4.Psychophysiology Unit at the Department of SurgeryMedical University of ViennaViennaAustria
  5. 5.Department of Biomedical EngineeringMedical University of ViennaViennaAustria

Personalised recommendations